These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
297 related items for PubMed ID: 18283626
1. Dendritic cell based immunotherapy--a promising therapeutic approach for endocrine malignancies. Sbiera S, Wortmann S, Fassnacht M. Horm Metab Res; 2008 Feb; 40(2):89-98. PubMed ID: 18283626 [Abstract] [Full Text] [Related]
2. Immunesurveillance by dendritic cells: potential implication for immunotherapy of endocrine cancers. Schott M. Endocr Relat Cancer; 2006 Sep; 13(3):779-95. PubMed ID: 16954430 [Abstract] [Full Text] [Related]
4. Dendritic cell-based immunotherapy. Osada T, Clay TM, Woo CY, Morse MA, Lyerly HK. Int Rev Immunol; 2006 Mar; 25(5-6):377-413. PubMed ID: 17169781 [Abstract] [Full Text] [Related]
5. Dendritic cells and their role in cancer immunotherapy. Jalili A. Iran J Immunol; 2007 Sep; 4(3):127-44. PubMed ID: 17767012 [Abstract] [Full Text] [Related]
9. Dendritic cells in cancer immunotherapy - a short review. Wojas K, Tabarkiewicz J, Roliński J. Folia Morphol (Warsz); 2003 Nov; 62(4):317-8. PubMed ID: 14655109 [Abstract] [Full Text] [Related]
10. Advances in specific immunotherapy for prostate cancer. Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M. Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335 [Abstract] [Full Text] [Related]
11. Development of vaccines against self-antigens: the p53 paradigm. Chada S, Mhashilkar A, Roth JA, Gabrilovich D. Curr Opin Drug Discov Devel; 2003 Mar; 6(2):169-73. PubMed ID: 12669451 [Abstract] [Full Text] [Related]
12. Current status and future perspectives of dendritic cell-based cancer immunotherapy. H Yi D, Appel S. Scand J Immunol; 2013 Aug; 78(2):167-71. PubMed ID: 23672402 [Abstract] [Full Text] [Related]
13. The use of dendritic cells in cancer immunotherapy. Nencioni A, Grünebach F, Schmidt SM, Müller MR, Boy D, Patrone F, Ballestrero A, Brossart P. Crit Rev Oncol Hematol; 2008 Mar; 65(3):191-9. PubMed ID: 18055210 [Abstract] [Full Text] [Related]
14. Novel immunotherapeutic strategies in gynecologic oncology. Dendritic cell-based immunotherapy for ovarian cancer. Santin AD, Bellone S, Underwood LJ, O'Brien TJ, Ravaggi A, Pecorelli S, Cannon MJ. Minerva Ginecol; 2002 Apr; 54(2):133-44. PubMed ID: 12032451 [Abstract] [Full Text] [Related]
15. Dendritic cells in cancer immunotherapy. Vulink A, Radford KJ, Melief C, Hart DN. Adv Cancer Res; 2008 Apr; 99():363-407. PubMed ID: 18037410 [Abstract] [Full Text] [Related]
16. Dendritic cell-based glioma immunotherapy (review). Yamanaka R, Yajima N, Abe T, Tsuchiya N, Homma J, Narita M, Takahashi M, Tanaka R. Int J Oncol; 2003 Jul; 23(1):5-15. PubMed ID: 12792771 [Abstract] [Full Text] [Related]
17. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials. Mossoba ME, Medin JA. Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444 [Abstract] [Full Text] [Related]
19. Immunotherapy of cancer using dendritic cells. Morse MA, Lyerly HK. Cytokines Cell Mol Ther; 1998 Mar 01; 4(1):35-44. PubMed ID: 9557215 [Abstract] [Full Text] [Related]
20. New frontiers in cell-based immunotherapy of cancer. D'Elios MM, Del Prete G, Amedei A. Expert Opin Ther Pat; 2009 May 01; 19(5):623-41. PubMed ID: 19441938 [Abstract] [Full Text] [Related] Page: [Next] [New Search]